MTCR Insider Trading

Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 13.80%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Metacrine Insider Trading History Chart

This chart shows the insider buying and selling history at Metacrine by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$400k-$200k$0$200k$400kTotal Insider BuyingTotal Insider Selling

Metacrine Share Price & Price History

Current Price: $0.58
Price Change: +0.30 (1.20%)
As of 06/20/2023 01:00 AM ET

This chart shows the closing price history over time for MTCR up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

SEC Filings (Institutional Ownership Changes) for Metacrine (NASDAQ:MTCR)

37.72% of Metacrine stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at MTCR by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
202220232024$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4-$4M-$2M$0$2M$4MTotal InflowsTotal Outflows
Metacrine logo
Metacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with gastrointestinal diseases. It is developing MET642, which has completed Phase I clinical trial for the treatment of ulcerative colitis. Metacrine, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Read More on Metacrine

Today's Range

Now: $0.58
Low: $0.58
High: $0.59

50 Day Range

MA: $0.57
Low: $0.55
High: $0.59

52 Week Range

Now: $0.58
Low: $0.30
High: $0.59

Volume

83,889 shs

Average Volume

225,834 shs

Market Capitalization

$24.75 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A